Assessing and Treating Patients with Bipolar Disorder: A Clinical Case Study

Overview

This paper presents a clinical case study of a 26-year-old Korean woman diagnosed with bipolar one disorder who was recently discharged from hospitalization for acute mania. The analysis examines therapeutic decision-making regarding medication selection and treatment compliance, evaluating the outcomes of lithium therapy initiation and the patient's adherence challenges.

What this case study covers

Preview

Assessing and Treating Patients with Bipolar Disorder

Name of Student

Institutional Affiliation

Course

Professor

Date

Assessing and Treating Patients with Bipolar Disorder

Introduction

Bipolar disorder, also known as manic depression, causes a person to experience frequent depression and euphoria. The condition, which is a form of mental illness, impairs the individual disposition and social settings due to abnormal activities. Bipolar disorder is characterized by symptoms such as mood swings, depression, and mania. The disorder becomes too complex, making it hard to diagnose other disorders such as schizophrenia since it has the same symptoms (Carvalho et al. 2020). The disorder always results in a series of episodes which makes the patient experience delusions and hallucinations. A chemical imbalance also characterizes the disorder, thus impairing the individual brain, which triggers mood swings. This paper will examine a 26-year-old woman diagnosed with bipolar disorder, and an attempt to make clinical decisions will be analyzed to optimize her treatment.

The client in line is 26 years old woman whose descent is Korean is in her first appointment since she was discharged from 21 days of hospitalization due to acute mania. On medical review, the woman was diagnosed with bipolar one disorder. The physician reported that the patient is in good health with the lab limits operating within the normal limits (Grande et al., 2016). The patient had GeneSight testing, with none of the medication failed to work for her. The genetic testing is a clear revelation that the patient is positive for the CYP2D6*10 allele.

More Nursing samples